Drug name - Zontivity
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7713999 | XSPIRE PHARMA | Thrombin receptor antagonists |
May, 2024
(1 year, 5 months from now) | |
| US7304078 | XSPIRE PHARMA | Thrombin receptor antagonists |
Dec, 2027
(5 years from now) | |
Drugs and Companies using VORAPAXAR SULFATE ingredient
Market Authorisation Date: 08 May, 2014
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 2.08MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.